Home

Subscription

November 2017 issue

October 2017 issue

September 2017 issue

August 2017 issue

July 2017 issue

June 2017 issue

May 2017 issue

April 1, 2017 issue

March 2017 issue

February 2017 issue

January 2017 issue



BACK ISSUES

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006


2010 Issues

December 2010 Issue
• Appreciation and Anticipation
• New Therapeutic Agents Marketed in the United States in 2010
• Index for 2006 – 2010


November 2010 Issue
• Feature - Strike 3 – CVS Should be OUT!
• New Drug Review: Dabigatran etexilate mesylate (Pradaxa)


October 2010 Issue
• Feature - Prescription Benefit Programs – Pharmacy Needs Greater Strength and New Strategies!
• New Drug Review: Polidocanol (Asclera)


September 2010 Issue
• Feature - CARE is Missing in Health Insurance Reform! Independent Pharmacists are Well Positioned to Provide It!
• New Drug Review: Dienogest/estradiol valerate (Natazia)


August 2010 Issue
• Feature - Who are Pharmacy's Leaders?
• New Drug Review: Tocilizumab (Actemra)


July 2010 Issue
• Feature - We Have TOO MANY Colleges of Pharmacy!
• New Drug Review: Denosumab (Prolia)


June 2010 Issue
• Feature - CVS Caremark's Participation in Medicare Prescription Programs should be Terminated!
• New Drug Review: Pitavastatin calcium (Livalo)


May 2010 Issue
• Feature - Herb Denenberg – The Ultimate Activist and a Great Friend of Pharmacy
• New Drug Review: Dalfampridine (Ampyra)


April 2010 Issue
• Feature - Pharmacy Must Develop Opportunities Now! (Before Health Insurance "Reform" Limits our Role)
• New Drug Review: Liraglutide (Victoza)


March 2010 Issue
• Feature - Tobacco Sales in Pharmacies – A Historic Decision by APhA Delegates
• New Drug Review: Ustekinumab (Stelara)


February 2010 Issue
• Feature - Dispensing Error – And a Pharmacist in Prison
• New Drug Review: Iloperidone (Fanapt)


January 2010 Issue
• Feature - Health Care Reform – Let's Start Over and Do It Right!
• New Drug Review: Asenapine (Saphris)